Patients suffering from neurodegenerative diseases: Amyotrophic Lateral Sclerosis (ALS) research hub

MEDICAL CANNABIS FOR NEURODEGENERATIVE DISEASES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II CLINICAL TRIAL (NEUROBIS)

This study looks at how a cannabis-based medicine, Avextra 10/10, might help people with Alzheimer's, Parkinson's, or ALS. Researchers want to see if it improves their quality of life and if it's safe to use, compared to a dummy treatment.